Jesper D. Gunst
@jespergunst.bsky.social
Clinical trialist working on clinical trials 😊
In the immunological control for #HIVcure session at #IAS2025, my friend @jespergunst.bsky.social presents beautifully about what we know & what we don’t know about predictors of post treatment control & post intervention control with a shout out to the HIV reservoirs consortium.
Time to #HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies www.nature.com/articles/s41... (open access) @naturecomms.bsky.social @jespergunst.bsky.social
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies - Nature Com...
Clinical trials testing efficacy of novel HIV treatments rely on analytical treatment interruption (ATI). Using data from 24 prospective studies, the authors here show that the virus becomes detectabl...
nature.com
Factors influencing virologic control during analytical treatment interruptions in #HIV cure trials – a pooled analysis of individual level data academic.oup.com/jid/advance-... (subscription req for full text) @jidjournal.bsky.social @jespergunst.bsky.social
Factors influencing virologic control during analytical treatment interruptions in HIV cure trials – a pooled analysis of individual level data
HIV-1 reservoir size and treatment with histone deacetylase inhibitors seem to influence time to loss of virologic control during analytical treatment inte
academic.oup.com
